Multicomponent Intervention to Reduce Sexual Risk and Substance Use



Status:Completed
Conditions:Infectious Disease, HIV / AIDS, Psychiatric
Therapuetic Areas:Immunology / Infectious Diseases, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:8/9/2018
Start Date:June 2013
End Date:November 2, 2017

Use our guide to learn which trials are right for you!

The objective is to expand and refine an intervention for transgender women (TW) into a
7-session individual- and group-based intervention that is scalable for community settings to
reduce sexual risk and substance use and to increase stigma-coping and risk-buffering
behaviors among TW in NYC. The investigators will pilot test the intervention with 20 TW and
subsequently, conduct a randomized controlled trial with 240 TW to compare the intervention
to a wait list control condition.


Inclusion Criteria:

- 18 years of age or older

- Identify as a transgender woman (assigned male at birth and currently identify as
female)

- Report 3 or more acts of unprotected anal or vaginal sex in the past 90 days and at
least 1 in the past 30 days

- Report 5 or more days of illicit drug use in the past 90 days and at least 2 in the
past 30

- Provide contact information

- Reside in the NYC metropolitan area

- Able to complete a survey in English (Spanish-language assistance can be provided by
bilingual staff)

- Provide informed consent

Exclusion Criteria:

- Unstable, serious psychiatric symptoms

- Current suicidal/homicidal ideation

- Evidence of gross cognitive impairment

- Currently enrolled in a drug abuse treatment or enrolled in an HIV risk or drug use
intervention study
We found this trial at
1
site
New York, New York 10001
Principal Investigator: Jeffrey T Parsons, Ph.D.
Phone: 212-206-7919
?
mi
from
New York, NY
Click here to add this to my saved trials